Myricx Pharma secured £4.5M from life sciences investors Sofinnova Partners and Brandon Capital Partners Health services Pharma Investments 17 November 2020 Original story Nordic 9 Interested in accessing all the deal flow, on the web or via email? Become a Nordic 9 Insider now!
Round Value (USD): $6.02MRound investors: Brandon Capital PartnersSofinnova PartnersCompany: Myricx PharmaIndustry: Health servicesPharma